Cor Therapeutics Inc. (CORR) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cor Therapeutics Inc. (CORR)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Labrador who wrote (205)	4/7/1998 6:50:00 PM
From: Andrew Q. Viet	Read Replies (1) of 712

The market is big enough for all the players. Eventually it will come down to the efficacy. The most efficacious one will sprint ahead, if the company knows how to position its product. I heard integrilin is the best one for unstable angina. The market cap for CORR is still under 500 mill, whereas, CNTO's market cap is more than 4 billion. If Integrilin does well, CORR has a lot of upside potential. Good luck to all

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next